Theravance Biopharma Free Cash Flow (Quarterly) Trends

Theravance Biopharma Inc (TBPH)

9.15 -0.06 (-0.65%) USD | NASDAQ | Apr 24, 15:12

Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	-1.531M
September 30, 2023	-2.507M
June 30, 2023	-13.29M
March 31, 2023	-12.16M
December 31, 2022	-124.32M
September 30, 2022	-22.08M
June 30, 2022	-14.84M
March 31, 2022	-26.32M
December 31, 2021	-42.88M
September 30, 2021	-46.48M
June 30, 2021	-50.27M
March 31, 2021	-71.63M
December 31, 2020	-66.17M
September 30, 2020	-79.08M
June 30, 2020	-55.71M
March 31, 2020	-56.06M
December 31, 2019	-65.66M
September 30, 2019	-44.70M
June 30, 2019	-48.61M
March 31, 2019	-82.41M
December 31, 2018	-53.68M
September 30, 2018	-50.85M

Date	Value
June 30, 2018	-62.63M
March 31, 2018	47.05M
December 31, 2017	-44.46M
September 30, 2017	-63.12M
June 30, 2017	-45.26M
March 31, 2017	-50.61M
December 31, 2016	-28.51M
September 30, 2016	-12.84M
June 30, 2016	-32.77M
March 31, 2016	-26.99M
December 31, 2015	-34.35M
September 30, 2015	-32.66M
June 30, 2015	-47.32M
March 31, 2015	-57.17M
December 31, 2014	-43.30M
September 30, 2014	-36.84M
June 30, 2014	-51.70M
March 31, 2014	-46.42M
December 31, 2013	-36.25M
September 30, 2013	-33.17M
June 30, 2013	-25.04M
March 31, 2013	-29.23M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

-124.32M

Minimum

Dec 2022

-1.531M

Maximum

Dec 2023

-44.44M

Average

-46.48M

Median

Sep 2021

Free Cash Flow (Quarterly) Benchmarks